Exclusive: Pfizer to cut U.S. sales staff as meetings with healthcare providers move to virtual
Pfizer Inc (PFE.N) said on Tuesday it is reducing its U.S. sales staff as it expects doctors and other healthcare providers to want fewer face-to-face interactions with sales people after the COVID-19 pandemic ends.
